GAS6

Across TCGA pan-cancer cohorts, GAS6 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of GAS6’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where GAS6 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GAS6 is over-expressed in tumor, although a few such as LUAD and LSCC show the opposite, repressed pattern.

LUAD, LSCC, and HNSC are the cancer types where GAS6 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAS6 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	III,IV	−0.549	<.001	9	view →
LSCC	Female	All	−0.574	<.001	8	view →
HNSC	All	III,IV	−0.266	<.001	6	view →
COAD	All	All	−0.519	.004	4	view →
CCRCC	All	All	+0.120	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

GAS6–LUAD

Open the LUAD breakdown →